超短時間作用型麻酔薬のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Ultra Short Acting Anesthetic Market Insights, Forecast to 2028

• レポートコード：QY2207E10508 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、127ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の超短時間作用型麻酔薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に超短時間作用型麻酔薬の世界市場のxxx％を占める「メチツラール」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院用」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の超短時間作用型麻酔薬の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの超短時間作用型麻酔薬市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの超短時間作用型麻酔薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 超短時間作用型麻酔薬のグローバル主要メーカーには、Paion、AstraZeneca、Fresenius-Kabi、BbVie Laboratories、Baxter Healthcare、Braun、Maruishi、Piramal Healthcare、Hikma Pharmaceuticals、Mylan、Nhwa、Lunan、Hengrui、Pfizer、Merck、Eli Lilly、Meda pharmaceuticals、Sanofi、Teva Pharmaceutical、Sumitomo Dainippon Pharma、Bausch Health、Oak Pharmaceuticalsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 超短時間作用型麻酔薬市場は、種類と用途によって区分されます。世界の超短時間作用型麻酔薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 メチツラール、ビファボ、メトヘキシタール、チアミラール、チオペンタール、プロポフォール 【用途別セグメント】 病院用、クリニック用、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 超短時間作用型麻酔薬製品概要 - 種類別市場（メチツラール、ビファボ、メトヘキシタール、チアミラール、チオペンタール、プロポフォール） - 用途別市場（病院用、クリニック用、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の超短時間作用型麻酔薬販売量予測2017-2028 - 世界の超短時間作用型麻酔薬売上予測2017-2028 - 超短時間作用型麻酔薬の地域別販売量 - 超短時間作用型麻酔薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別超短時間作用型麻酔薬販売量 - 主要メーカー別超短時間作用型麻酔薬売上 - 主要メーカー別超短時間作用型麻酔薬価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（メチツラール、ビファボ、メトヘキシタール、チアミラール、チオペンタール、プロポフォール） - 超短時間作用型麻酔薬の種類別販売量 - 超短時間作用型麻酔薬の種類別売上 - 超短時間作用型麻酔薬の種類別価格 ・用途別市場規模（病院用、クリニック用、その他） - 超短時間作用型麻酔薬の用途別販売量 - 超短時間作用型麻酔薬の用途別売上 - 超短時間作用型麻酔薬の用途別価格 ・北米市場 - 北米の超短時間作用型麻酔薬市場規模（種類別、用途別） - 主要国別の超短時間作用型麻酔薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの超短時間作用型麻酔薬市場規模（種類別、用途別） - 主要国別の超短時間作用型麻酔薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の超短時間作用型麻酔薬市場規模（種類別、用途別） - 主要国別の超短時間作用型麻酔薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の超短時間作用型麻酔薬市場規模（種類別、用途別） - 主要国別の超短時間作用型麻酔薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの超短時間作用型麻酔薬市場規模（種類別、用途別） - 主要国別の超短時間作用型麻酔薬市場規模（トルコ、サウジアラビア） ・企業情報 Paion、AstraZeneca、Fresenius-Kabi、BbVie Laboratories、Baxter Healthcare、Braun、Maruishi、Piramal Healthcare、Hikma Pharmaceuticals、Mylan、Nhwa、Lunan、Hengrui、Pfizer、Merck、Eli Lilly、Meda pharmaceuticals、Sanofi、Teva Pharmaceutical、Sumitomo Dainippon Pharma、Bausch Health、Oak Pharmaceuticals ・産業チェーン及び販売チャネル分析 - 超短時間作用型麻酔薬の産業チェーン分析 - 超短時間作用型麻酔薬の原材料 - 超短時間作用型麻酔薬の生産プロセス - 超短時間作用型麻酔薬の販売及びマーケティング - 超短時間作用型麻酔薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 超短時間作用型麻酔薬の産業動向 - 超短時間作用型麻酔薬のマーケットドライバー - 超短時間作用型麻酔薬の課題 - 超短時間作用型麻酔薬の阻害要因 ・主な調査結果

Market Analysis and Insights: Global Ultra Short Acting Anesthetic Market
Due to the COVID-19 pandemic, the global Ultra Short Acting Anesthetic market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Methitural accounting for % of the Ultra Short Acting Anesthetic global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Use segment is altered to an % CAGR throughout this forecast period.
China Ultra Short Acting Anesthetic market size is valued at US$ million in 2021, while the US and Europe Ultra Short Acting Anesthetic are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Ultra Short Acting Anesthetic landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Ultra Short Acting Anesthetic include Paion, AstraZeneca, Fresenius-Kabi, BbVie Laboratories, Baxter Healthcare, Braun, Maruishi, Piramal Healthcare and Hikma Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Ultra Short Acting Anesthetic Scope and Segment
Ultra Short Acting Anesthetic market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Ultra Short Acting Anesthetic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Methitural
Byfavo
Methohexital
Thiamylal
Thiopental
Propofol
Segment by Application
Hospital Use
Clinic Use
Others
By Company
Paion
AstraZeneca
Fresenius-Kabi
BbVie Laboratories
Baxter Healthcare
Braun
Maruishi
Piramal Healthcare
Hikma Pharmaceuticals
Mylan
Nhwa
Lunan
Hengrui
Pfizer
Merck
Eli Lilly
Meda pharmaceuticals
Sanofi
Teva Pharmaceutical
Sumitomo Dainippon Pharma
Bausch Health
Oak Pharmaceuticals
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Ultra Short Acting Anesthetic Product Introduction
1.2 Market by Type
1.2.1 Global Ultra Short Acting Anesthetic Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Methitural
1.2.3 Byfavo
1.2.4 Methohexital
1.2.5 Thiamylal
1.2.6 Thiopental
1.2.7 Propofol
1.3 Market by Application
1.3.1 Global Ultra Short Acting Anesthetic Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Use
1.3.3 Clinic Use
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Ultra Short Acting Anesthetic Sales Estimates and Forecasts 2017-2028
2.2 Global Ultra Short Acting Anesthetic Revenue Estimates and Forecasts 2017-2028
2.3 Global Ultra Short Acting Anesthetic Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Ultra Short Acting Anesthetic Sales by Region
2.4.1 Global Ultra Short Acting Anesthetic Sales by Region (2017-2022)
2.4.2 Global Sales Ultra Short Acting Anesthetic by Region (2023-2028)
2.5 Global Ultra Short Acting Anesthetic Revenue by Region
2.5.1 Global Ultra Short Acting Anesthetic Revenue by Region (2017-2022)
2.5.2 Global Ultra Short Acting Anesthetic Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Ultra Short Acting Anesthetic Sales by Manufacturers
3.1.1 Global Top Ultra Short Acting Anesthetic Manufacturers by Sales (2017-2022)
3.1.2 Global Ultra Short Acting Anesthetic Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Ultra Short Acting Anesthetic in 2021
3.2 Global Ultra Short Acting Anesthetic Revenue by Manufacturers
3.2.1 Global Ultra Short Acting Anesthetic Revenue by Manufacturers (2017-2022)
3.2.2 Global Ultra Short Acting Anesthetic Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Ultra Short Acting Anesthetic Revenue in 2021
3.3 Global Ultra Short Acting Anesthetic Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Ultra Short Acting Anesthetic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Ultra Short Acting Anesthetic Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Ultra Short Acting Anesthetic Sales by Type
4.1.1 Global Ultra Short Acting Anesthetic Historical Sales by Type (2017-2022)
4.1.2 Global Ultra Short Acting Anesthetic Forecasted Sales by Type (2023-2028)
4.1.3 Global Ultra Short Acting Anesthetic Sales Market Share by Type (2017-2028)
4.2 Global Ultra Short Acting Anesthetic Revenue by Type
4.2.1 Global Ultra Short Acting Anesthetic Historical Revenue by Type (2017-2022)
4.2.2 Global Ultra Short Acting Anesthetic Forecasted Revenue by Type (2023-2028)
4.2.3 Global Ultra Short Acting Anesthetic Revenue Market Share by Type (2017-2028)
4.3 Global Ultra Short Acting Anesthetic Price by Type
4.3.1 Global Ultra Short Acting Anesthetic Price by Type (2017-2022)
4.3.2 Global Ultra Short Acting Anesthetic Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Ultra Short Acting Anesthetic Sales by Application
5.1.1 Global Ultra Short Acting Anesthetic Historical Sales by Application (2017-2022)
5.1.2 Global Ultra Short Acting Anesthetic Forecasted Sales by Application (2023-2028)
5.1.3 Global Ultra Short Acting Anesthetic Sales Market Share by Application (2017-2028)
5.2 Global Ultra Short Acting Anesthetic Revenue by Application
5.2.1 Global Ultra Short Acting Anesthetic Historical Revenue by Application (2017-2022)
5.2.2 Global Ultra Short Acting Anesthetic Forecasted Revenue by Application (2023-2028)
5.2.3 Global Ultra Short Acting Anesthetic Revenue Market Share by Application (2017-2028)
5.3 Global Ultra Short Acting Anesthetic Price by Application
5.3.1 Global Ultra Short Acting Anesthetic Price by Application (2017-2022)
5.3.2 Global Ultra Short Acting Anesthetic Price Forecast by Application (2023-2028)
6 North America
6.1 North America Ultra Short Acting Anesthetic Market Size by Type
6.1.1 North America Ultra Short Acting Anesthetic Sales by Type (2017-2028)
6.1.2 North America Ultra Short Acting Anesthetic Revenue by Type (2017-2028)
6.2 North America Ultra Short Acting Anesthetic Market Size by Application
6.2.1 North America Ultra Short Acting Anesthetic Sales by Application (2017-2028)
6.2.2 North America Ultra Short Acting Anesthetic Revenue by Application (2017-2028)
6.3 North America Ultra Short Acting Anesthetic Market Size by Country
6.3.1 North America Ultra Short Acting Anesthetic Sales by Country (2017-2028)
6.3.2 North America Ultra Short Acting Anesthetic Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Ultra Short Acting Anesthetic Market Size by Type
7.1.1 Europe Ultra Short Acting Anesthetic Sales by Type (2017-2028)
7.1.2 Europe Ultra Short Acting Anesthetic Revenue by Type (2017-2028)
7.2 Europe Ultra Short Acting Anesthetic Market Size by Application
7.2.1 Europe Ultra Short Acting Anesthetic Sales by Application (2017-2028)
7.2.2 Europe Ultra Short Acting Anesthetic Revenue by Application (2017-2028)
7.3 Europe Ultra Short Acting Anesthetic Market Size by Country
7.3.1 Europe Ultra Short Acting Anesthetic Sales by Country (2017-2028)
7.3.2 Europe Ultra Short Acting Anesthetic Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Ultra Short Acting Anesthetic Market Size by Type
8.1.1 Asia Pacific Ultra Short Acting Anesthetic Sales by Type (2017-2028)
8.1.2 Asia Pacific Ultra Short Acting Anesthetic Revenue by Type (2017-2028)
8.2 Asia Pacific Ultra Short Acting Anesthetic Market Size by Application
8.2.1 Asia Pacific Ultra Short Acting Anesthetic Sales by Application (2017-2028)
8.2.2 Asia Pacific Ultra Short Acting Anesthetic Revenue by Application (2017-2028)
8.3 Asia Pacific Ultra Short Acting Anesthetic Market Size by Region
8.3.1 Asia Pacific Ultra Short Acting Anesthetic Sales by Region (2017-2028)
8.3.2 Asia Pacific Ultra Short Acting Anesthetic Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Ultra Short Acting Anesthetic Market Size by Type
9.1.1 Latin America Ultra Short Acting Anesthetic Sales by Type (2017-2028)
9.1.2 Latin America Ultra Short Acting Anesthetic Revenue by Type (2017-2028)
9.2 Latin America Ultra Short Acting Anesthetic Market Size by Application
9.2.1 Latin America Ultra Short Acting Anesthetic Sales by Application (2017-2028)
9.2.2 Latin America Ultra Short Acting Anesthetic Revenue by Application (2017-2028)
9.3 Latin America Ultra Short Acting Anesthetic Market Size by Country
9.3.1 Latin America Ultra Short Acting Anesthetic Sales by Country (2017-2028)
9.3.2 Latin America Ultra Short Acting Anesthetic Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Ultra Short Acting Anesthetic Market Size by Type
10.1.1 Middle East and Africa Ultra Short Acting Anesthetic Sales by Type (2017-2028)
10.1.2 Middle East and Africa Ultra Short Acting Anesthetic Revenue by Type (2017-2028)
10.2 Middle East and Africa Ultra Short Acting Anesthetic Market Size by Application
10.2.1 Middle East and Africa Ultra Short Acting Anesthetic Sales by Application (2017-2028)
10.2.2 Middle East and Africa Ultra Short Acting Anesthetic Revenue by Application (2017-2028)
10.3 Middle East and Africa Ultra Short Acting Anesthetic Market Size by Country
10.3.1 Middle East and Africa Ultra Short Acting Anesthetic Sales by Country (2017-2028)
10.3.2 Middle East and Africa Ultra Short Acting Anesthetic Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Paion
11.1.1 Paion Corporation Information
11.1.2 Paion Overview
11.1.3 Paion Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Paion Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Paion Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AstraZeneca Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca Recent Developments
11.3 Fresenius-Kabi
11.3.1 Fresenius-Kabi Corporation Information
11.3.2 Fresenius-Kabi Overview
11.3.3 Fresenius-Kabi Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Fresenius-Kabi Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Fresenius-Kabi Recent Developments
11.4 BbVie Laboratories
11.4.1 BbVie Laboratories Corporation Information
11.4.2 BbVie Laboratories Overview
11.4.3 BbVie Laboratories Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 BbVie Laboratories Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 BbVie Laboratories Recent Developments
11.5 Baxter Healthcare
11.5.1 Baxter Healthcare Corporation Information
11.5.2 Baxter Healthcare Overview
11.5.3 Baxter Healthcare Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Baxter Healthcare Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Baxter Healthcare Recent Developments
11.6 Braun
11.6.1 Braun Corporation Information
11.6.2 Braun Overview
11.6.3 Braun Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Braun Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Braun Recent Developments
11.7 Maruishi
11.7.1 Maruishi Corporation Information
11.7.2 Maruishi Overview
11.7.3 Maruishi Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Maruishi Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Maruishi Recent Developments
11.8 Piramal Healthcare
11.8.1 Piramal Healthcare Corporation Information
11.8.2 Piramal Healthcare Overview
11.8.3 Piramal Healthcare Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Piramal Healthcare Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Piramal Healthcare Recent Developments
11.9 Hikma Pharmaceuticals
11.9.1 Hikma Pharmaceuticals Corporation Information
11.9.2 Hikma Pharmaceuticals Overview
11.9.3 Hikma Pharmaceuticals Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Hikma Pharmaceuticals Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Hikma Pharmaceuticals Recent Developments
11.10 Mylan
11.10.1 Mylan Corporation Information
11.10.2 Mylan Overview
11.10.3 Mylan Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Mylan Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Mylan Recent Developments
11.11 Nhwa
11.11.1 Nhwa Corporation Information
11.11.2 Nhwa Overview
11.11.3 Nhwa Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Nhwa Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Nhwa Recent Developments
11.12 Lunan
11.12.1 Lunan Corporation Information
11.12.2 Lunan Overview
11.12.3 Lunan Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Lunan Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Lunan Recent Developments
11.13 Hengrui
11.13.1 Hengrui Corporation Information
11.13.2 Hengrui Overview
11.13.3 Hengrui Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Hengrui Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Hengrui Recent Developments
11.14 Pfizer
11.14.1 Pfizer Corporation Information
11.14.2 Pfizer Overview
11.14.3 Pfizer Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Pfizer Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Pfizer Recent Developments
11.15 Merck
11.15.1 Merck Corporation Information
11.15.2 Merck Overview
11.15.3 Merck Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Merck Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Merck Recent Developments
11.16 Eli Lilly
11.16.1 Eli Lilly Corporation Information
11.16.2 Eli Lilly Overview
11.16.3 Eli Lilly Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Eli Lilly Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Eli Lilly Recent Developments
11.17 Meda pharmaceuticals
11.17.1 Meda pharmaceuticals Corporation Information
11.17.2 Meda pharmaceuticals Overview
11.17.3 Meda pharmaceuticals Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Meda pharmaceuticals Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Meda pharmaceuticals Recent Developments
11.18 Sanofi
11.18.1 Sanofi Corporation Information
11.18.2 Sanofi Overview
11.18.3 Sanofi Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Sanofi Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Sanofi Recent Developments
11.19 Teva Pharmaceutical
11.19.1 Teva Pharmaceutical Corporation Information
11.19.2 Teva Pharmaceutical Overview
11.19.3 Teva Pharmaceutical Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Teva Pharmaceutical Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Teva Pharmaceutical Recent Developments
11.20 Sumitomo Dainippon Pharma
11.20.1 Sumitomo Dainippon Pharma Corporation Information
11.20.2 Sumitomo Dainippon Pharma Overview
11.20.3 Sumitomo Dainippon Pharma Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Sumitomo Dainippon Pharma Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Sumitomo Dainippon Pharma Recent Developments
11.21 Bausch Health
11.21.1 Bausch Health Corporation Information
11.21.2 Bausch Health Overview
11.21.3 Bausch Health Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Bausch Health Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Bausch Health Recent Developments
11.22 Oak Pharmaceuticals
11.22.1 Oak Pharmaceuticals Corporation Information
11.22.2 Oak Pharmaceuticals Overview
11.22.3 Oak Pharmaceuticals Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 Oak Pharmaceuticals Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Oak Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Ultra Short Acting Anesthetic Industry Chain Analysis
12.2 Ultra Short Acting Anesthetic Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Ultra Short Acting Anesthetic Production Mode & Process
12.4 Ultra Short Acting Anesthetic Sales and Marketing
12.4.1 Ultra Short Acting Anesthetic Sales Channels
12.4.2 Ultra Short Acting Anesthetic Distributors
12.5 Ultra Short Acting Anesthetic Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Ultra Short Acting Anesthetic Industry Trends
13.2 Ultra Short Acting Anesthetic Market Drivers
13.3 Ultra Short Acting Anesthetic Market Challenges
13.4 Ultra Short Acting Anesthetic Market Restraints
14 Key Findings in The Global Ultra Short Acting Anesthetic Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Ultra Short Acting Anesthetic Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Methitural
Table 3. Major Manufacturers of Byfavo
Table 4. Major Manufacturers of Methohexital
Table 5. Major Manufacturers of Thiamylal
Table 6. Major Manufacturers of Thiopental
Table 7. Major Manufacturers of Propofol
Table 8. Global Ultra Short Acting Anesthetic Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Ultra Short Acting Anesthetic Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Ultra Short Acting Anesthetic Sales by Region (2017-2022) & (K Units)
Table 11. Global Ultra Short Acting Anesthetic Sales Market Share by Region (2017-2022)
Table 12. Global Ultra Short Acting Anesthetic Sales by Region (2023-2028) & (K Units)
Table 13. Global Ultra Short Acting Anesthetic Sales Market Share by Region (2023-2028)
Table 14. Global Ultra Short Acting Anesthetic Revenue by Region (2017-2022) & (US$ Million)
Table 15. Global Ultra Short Acting Anesthetic Revenue Market Share by Region (2017-2022)
Table 16. Global Ultra Short Acting Anesthetic Revenue by Region (2023-2028) & (US$ Million)
Table 17. Global Ultra Short Acting Anesthetic Revenue Market Share by Region (2023-2028)
Table 18. Global Ultra Short Acting Anesthetic Sales by Manufacturers (2017-2022) & (K Units)
Table 19. Global Ultra Short Acting Anesthetic Sales Share by Manufacturers (2017-2022)
Table 20. Global Ultra Short Acting Anesthetic Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 21. Global Ultra Short Acting Anesthetic Revenue Share by Manufacturers (2017-2022)
Table 22. Ultra Short Acting Anesthetic Price by Manufacturers (2017-2022) &(US$/Unit)
Table 23. Global Ultra Short Acting Anesthetic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Ultra Short Acting Anesthetic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ultra Short Acting Anesthetic as of 2021)
Table 25. Ultra Short Acting Anesthetic Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Ultra Short Acting Anesthetic Product Offered
Table 27. Date of Manufacturers Enter into Ultra Short Acting Anesthetic Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Ultra Short Acting Anesthetic Sales by Type (2017-2022) & (K Units)
Table 30. Global Ultra Short Acting Anesthetic Sales by Type (2023-2028) & (K Units)
Table 31. Global Ultra Short Acting Anesthetic Sales Share by Type (2017-2022)
Table 32. Global Ultra Short Acting Anesthetic Sales Share by Type (2023-2028)
Table 33. Global Ultra Short Acting Anesthetic Revenue by Type (2017-2022) & (US$ Million)
Table 34. Global Ultra Short Acting Anesthetic Revenue by Type (2023-2028) & (US$ Million)
Table 35. Global Ultra Short Acting Anesthetic Revenue Share by Type (2017-2022)
Table 36. Global Ultra Short Acting Anesthetic Revenue Share by Type (2023-2028)
Table 37. Ultra Short Acting Anesthetic Price by Type (2017-2022) & (US$/Unit)
Table 38. Global Ultra Short Acting Anesthetic Price Forecast by Type (2023-2028) & (US$/Unit)
Table 39. Global Ultra Short Acting Anesthetic Sales by Application (2017-2022) & (K Units)
Table 40. Global Ultra Short Acting Anesthetic Sales by Application (2023-2028) & (K Units)
Table 41. Global Ultra Short Acting Anesthetic Sales Share by Application (2017-2022)
Table 42. Global Ultra Short Acting Anesthetic Sales Share by Application (2023-2028)
Table 43. Global Ultra Short Acting Anesthetic Revenue by Application (2017-2022) & (US$ Million)
Table 44. Global Ultra Short Acting Anesthetic Revenue by Application (2023-2028) & (US$ Million)
Table 45. Global Ultra Short Acting Anesthetic Revenue Share by Application (2017-2022)
Table 46. Global Ultra Short Acting Anesthetic Revenue Share by Application (2023-2028)
Table 47. Ultra Short Acting Anesthetic Price by Application (2017-2022) & (US$/Unit)
Table 48. Global Ultra Short Acting Anesthetic Price Forecast by Application (2023-2028) & (US$/Unit)
Table 49. North America Ultra Short Acting Anesthetic Sales by Type (2017-2022) & (K Units)
Table 50. North America Ultra Short Acting Anesthetic Sales by Type (2023-2028) & (K Units)
Table 51. North America Ultra Short Acting Anesthetic Revenue by Type (2017-2022) & (US$ Million)
Table 52. North America Ultra Short Acting Anesthetic Revenue by Type (2023-2028) & (US$ Million)
Table 53. North America Ultra Short Acting Anesthetic Sales by Application (2017-2022) & (K Units)
Table 54. North America Ultra Short Acting Anesthetic Sales by Application (2023-2028) & (K Units)
Table 55. North America Ultra Short Acting Anesthetic Revenue by Application (2017-2022) & (US$ Million)
Table 56. North America Ultra Short Acting Anesthetic Revenue by Application (2023-2028) & (US$ Million)
Table 57. North America Ultra Short Acting Anesthetic Sales by Country (2017-2022) & (K Units)
Table 58. North America Ultra Short Acting Anesthetic Sales by Country (2023-2028) & (K Units)
Table 59. North America Ultra Short Acting Anesthetic Revenue by Country (2017-2022) & (US$ Million)
Table 60. North America Ultra Short Acting Anesthetic Revenue by Country (2023-2028) & (US$ Million)
Table 61. Europe Ultra Short Acting Anesthetic Sales by Type (2017-2022) & (K Units)
Table 62. Europe Ultra Short Acting Anesthetic Sales by Type (2023-2028) & (K Units)
Table 63. Europe Ultra Short Acting Anesthetic Revenue by Type (2017-2022) & (US$ Million)
Table 64. Europe Ultra Short Acting Anesthetic Revenue by Type (2023-2028) & (US$ Million)
Table 65. Europe Ultra Short Acting Anesthetic Sales by Application (2017-2022) & (K Units)
Table 66. Europe Ultra Short Acting Anesthetic Sales by Application (2023-2028) & (K Units)
Table 67. Europe Ultra Short Acting Anesthetic Revenue by Application (2017-2022) & (US$ Million)
Table 68. Europe Ultra Short Acting Anesthetic Revenue by Application (2023-2028) & (US$ Million)
Table 69. Europe Ultra Short Acting Anesthetic Sales by Country (2017-2022) & (K Units)
Table 70. Europe Ultra Short Acting Anesthetic Sales by Country (2023-2028) & (K Units)
Table 71. Europe Ultra Short Acting Anesthetic Revenue by Country (2017-2022) & (US$ Million)
Table 72. Europe Ultra Short Acting Anesthetic Revenue by Country (2023-2028) & (US$ Million)
Table 73. Asia Pacific Ultra Short Acting Anesthetic Sales by Type (2017-2022) & (K Units)
Table 74. Asia Pacific Ultra Short Acting Anesthetic Sales by Type (2023-2028) & (K Units)
Table 75. Asia Pacific Ultra Short Acting Anesthetic Revenue by Type (2017-2022) & (US$ Million)
Table 76. Asia Pacific Ultra Short Acting Anesthetic Revenue by Type (2023-2028) & (US$ Million)
Table 77. Asia Pacific Ultra Short Acting Anesthetic Sales by Application (2017-2022) & (K Units)
Table 78. Asia Pacific Ultra Short Acting Anesthetic Sales by Application (2023-2028) & (K Units)
Table 79. Asia Pacific Ultra Short Acting Anesthetic Revenue by Application (2017-2022) & (US$ Million)
Table 80. Asia Pacific Ultra Short Acting Anesthetic Revenue by Application (2023-2028) & (US$ Million)
Table 81. Asia Pacific Ultra Short Acting Anesthetic Sales by Region (2017-2022) & (K Units)
Table 82. Asia Pacific Ultra Short Acting Anesthetic Sales by Region (2023-2028) & (K Units)
Table 83. Asia Pacific Ultra Short Acting Anesthetic Revenue by Region (2017-2022) & (US$ Million)
Table 84. Asia Pacific Ultra Short Acting Anesthetic Revenue by Region (2023-2028) & (US$ Million)
Table 85. Latin America Ultra Short Acting Anesthetic Sales by Type (2017-2022) & (K Units)
Table 86. Latin America Ultra Short Acting Anesthetic Sales by Type (2023-2028) & (K Units)
Table 87. Latin America Ultra Short Acting Anesthetic Revenue by Type (2017-2022) & (US$ Million)
Table 88. Latin America Ultra Short Acting Anesthetic Revenue by Type (2023-2028) & (US$ Million)
Table 89. Latin America Ultra Short Acting Anesthetic Sales by Application (2017-2022) & (K Units)
Table 90. Latin America Ultra Short Acting Anesthetic Sales by Application (2023-2028) & (K Units)
Table 91. Latin America Ultra Short Acting Anesthetic Revenue by Application (2017-2022) & (US$ Million)
Table 92. Latin America Ultra Short Acting Anesthetic Revenue by Application (2023-2028) & (US$ Million)
Table 93. Latin America Ultra Short Acting Anesthetic Sales by Country (2017-2022) & (K Units)
Table 94. Latin America Ultra Short Acting Anesthetic Sales by Country (2023-2028) & (K Units)
Table 95. Latin America Ultra Short Acting Anesthetic Revenue by Country (2017-2022) & (US$ Million)
Table 96. Latin America Ultra Short Acting Anesthetic Revenue by Country (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Ultra Short Acting Anesthetic Sales by Type (2017-2022) & (K Units)
Table 98. Middle East and Africa Ultra Short Acting Anesthetic Sales by Type (2023-2028) & (K Units)
Table 99. Middle East and Africa Ultra Short Acting Anesthetic Revenue by Type (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Ultra Short Acting Anesthetic Revenue by Type (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Ultra Short Acting Anesthetic Sales by Application (2017-2022) & (K Units)
Table 102. Middle East and Africa Ultra Short Acting Anesthetic Sales by Application (2023-2028) & (K Units)
Table 103. Middle East and Africa Ultra Short Acting Anesthetic Revenue by Application (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Ultra Short Acting Anesthetic Revenue by Application (2023-2028) & (US$ Million)
Table 105. Middle East and Africa Ultra Short Acting Anesthetic Sales by Country (2017-2022) & (K Units)
Table 106. Middle East and Africa Ultra Short Acting Anesthetic Sales by Country (2023-2028) & (K Units)
Table 107. Middle East and Africa Ultra Short Acting Anesthetic Revenue by Country (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Ultra Short Acting Anesthetic Revenue by Country (2023-2028) & (US$ Million)
Table 109. Paion Corporation Information
Table 110. Paion Description and Major Businesses
Table 111. Paion Ultra Short Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Paion Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Paion Recent Developments
Table 114. AstraZeneca Corporation Information
Table 115. AstraZeneca Description and Major Businesses
Table 116. AstraZeneca Ultra Short Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. AstraZeneca Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. AstraZeneca Recent Developments
Table 119. Fresenius-Kabi Corporation Information
Table 120. Fresenius-Kabi Description and Major Businesses
Table 121. Fresenius-Kabi Ultra Short Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. Fresenius-Kabi Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Fresenius-Kabi Recent Developments
Table 124. BbVie Laboratories Corporation Information
Table 125. BbVie Laboratories Description and Major Businesses
Table 126. BbVie Laboratories Ultra Short Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. BbVie Laboratories Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. BbVie Laboratories Recent Developments
Table 129. Baxter Healthcare Corporation Information
Table 130. Baxter Healthcare Description and Major Businesses
Table 131. Baxter Healthcare Ultra Short Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 132. Baxter Healthcare Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Baxter Healthcare Recent Developments
Table 134. Braun Corporation Information
Table 135. Braun Description and Major Businesses
Table 136. Braun Ultra Short Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 137. Braun Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Braun Recent Developments
Table 139. Maruishi Corporation Information
Table 140. Maruishi Description and Major Businesses
Table 141. Maruishi Ultra Short Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 142. Maruishi Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Maruishi Recent Developments
Table 144. Piramal Healthcare Corporation Information
Table 145. Piramal Healthcare Description and Major Businesses
Table 146. Piramal Healthcare Ultra Short Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 147. Piramal Healthcare Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Piramal Healthcare Recent Developments
Table 149. Hikma Pharmaceuticals Corporation Information
Table 150. Hikma Pharmaceuticals Description and Major Businesses
Table 151. Hikma Pharmaceuticals Ultra Short Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 152. Hikma Pharmaceuticals Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Hikma Pharmaceuticals Recent Developments
Table 154. Mylan Corporation Information
Table 155. Mylan Description and Major Businesses
Table 156. Mylan Ultra Short Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 157. Mylan Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Mylan Recent Developments
Table 159. Nhwa Corporation Information
Table 160. Nhwa Description and Major Businesses
Table 161. Nhwa Ultra Short Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 162. Nhwa Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Nhwa Recent Developments
Table 164. Lunan Corporation Information
Table 165. Lunan Description and Major Businesses
Table 166. Lunan Ultra Short Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 167. Lunan Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. Lunan Recent Developments
Table 169. Hengrui Corporation Information
Table 170. Hengrui Description and Major Businesses
Table 171. Hengrui Ultra Short Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 172. Hengrui Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 173. Hengrui Recent Developments
Table 174. Pfizer Corporation Information
Table 175. Pfizer Description and Major Businesses
Table 176. Pfizer Ultra Short Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 177. Pfizer Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 178. Pfizer Recent Developments
Table 179. Merck Corporation Information
Table 180. Merck Description and Major Businesses
Table 181. Merck Ultra Short Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 182. Merck Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 183. Merck Recent Developments
Table 184. Eli Lilly Corporation Information
Table 185. Eli Lilly Description and Major Businesses
Table 186. Eli Lilly Ultra Short Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 187. Eli Lilly Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 188. Eli Lilly Recent Developments
Table 189. Meda pharmaceuticals Corporation Information
Table 190. Meda pharmaceuticals Description and Major Businesses
Table 191. Meda pharmaceuticals Ultra Short Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 192. Meda pharmaceuticals Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 193. Meda pharmaceuticals Recent Developments
Table 194. Sanofi Corporation Information
Table 195. Sanofi Description and Major Businesses
Table 196. Sanofi Ultra Short Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 197. Sanofi Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 198. Sanofi Recent Developments
Table 199. Teva Pharmaceutical Corporation Information
Table 200. Teva Pharmaceutical Description and Major Businesses
Table 201. Teva Pharmaceutical Ultra Short Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 202. Teva Pharmaceutical Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 203. Teva Pharmaceutical Recent Developments
Table 204. Sumitomo Dainippon Pharma Corporation Information
Table 205. Sumitomo Dainippon Pharma Description and Major Businesses
Table 206. Sumitomo Dainippon Pharma Ultra Short Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 207. Sumitomo Dainippon Pharma Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 208. Sumitomo Dainippon Pharma Recent Developments
Table 209. Bausch Health Corporation Information
Table 210. Bausch Health Description and Major Businesses
Table 211. Bausch Health Ultra Short Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 212. Bausch Health Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 213. Bausch Health Recent Developments
Table 214. Oak Pharmaceuticals Corporation Information
Table 215. Oak Pharmaceuticals Description and Major Businesses
Table 216. Oak Pharmaceuticals Ultra Short Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 217. Oak Pharmaceuticals Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 218. Oak Pharmaceuticals Recent Developments
Table 219. Key Raw Materials Lists
Table 220. Raw Materials Key Suppliers Lists
Table 221. Ultra Short Acting Anesthetic Distributors List
Table 222. Ultra Short Acting Anesthetic Customers List
Table 223. Ultra Short Acting Anesthetic Market Trends
Table 224. Ultra Short Acting Anesthetic Market Drivers
Table 225. Ultra Short Acting Anesthetic Market Challenges
Table 226. Ultra Short Acting Anesthetic Market Restraints
Table 227. Research Programs/Design for This Report
Table 228. Key Data Information from Secondary Sources
Table 229. Key Data Information from Primary Sources
List of Figures
Figure 1. Ultra Short Acting Anesthetic Product Picture
Figure 3. Global Ultra Short Acting Anesthetic Market Share by Type in 2021 & 2028
Figure 3. Methitural Product Picture
Figure 4. Byfavo Product Picture
Figure 5. Methohexital Product Picture
Figure 6. Thiamylal Product Picture
Figure 7. Thiopental Product Picture
Figure 8. Propofol Product Picture
Figure 9. Global Ultra Short Acting Anesthetic Market Share by Application in 2021 & 2028
Figure 10. Hospital Use
Figure 11. Clinic Use
Figure 12. Others
Figure 13. Ultra Short Acting Anesthetic Report Years Considered
Figure 14. Global Ultra Short Acting Anesthetic Sales 2017-2028 (K Units)
Figure 15. Global Ultra Short Acting Anesthetic Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Ultra Short Acting Anesthetic Revenue 2017-2028 (US$ Million)
Figure 17. Global Ultra Short Acting Anesthetic Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 18. Global Ultra Short Acting Anesthetic Sales Market Share by Region (2017-2022)
Figure 19. Global Ultra Short Acting Anesthetic Sales Market Share by Region (2023-2028)
Figure 20. North America Ultra Short Acting Anesthetic Sales YoY (2017-2028) & (K Units)
Figure 21. North America Ultra Short Acting Anesthetic Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Europe Ultra Short Acting Anesthetic Sales YoY (2017-2028) & (K Units)
Figure 23. Europe Ultra Short Acting Anesthetic Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Asia-Pacific Ultra Short Acting Anesthetic Sales YoY (2017-2028) & (K Units)
Figure 25. Asia-Pacific Ultra Short Acting Anesthetic Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Latin America Ultra Short Acting Anesthetic Sales YoY (2017-2028) & (K Units)
Figure 27. Latin America Ultra Short Acting Anesthetic Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Middle East & Africa Ultra Short Acting Anesthetic Sales YoY (2017-2028) & (K Units)
Figure 29. Middle East & Africa Ultra Short Acting Anesthetic Revenue YoY (2017-2028) & (US$ Million)
Figure 30. The Ultra Short Acting Anesthetic Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 31. The Top 5 and 10 Largest Manufacturers of Ultra Short Acting Anesthetic in the World: Market Share by Ultra Short Acting Anesthetic Revenue in 2021
Figure 32. Global Ultra Short Acting Anesthetic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 33. Global Ultra Short Acting Anesthetic Sales Market Share by Type (2017-2028)
Figure 34. Global Ultra Short Acting Anesthetic Revenue Market Share by Type (2017-2028)
Figure 35. Global Ultra Short Acting Anesthetic Sales Market Share by Application (2017-2028)
Figure 36. Global Ultra Short Acting Anesthetic Revenue Market Share by Application (2017-2028)
Figure 37. North America Ultra Short Acting Anesthetic Sales Market Share by Type (2017-2028)
Figure 38. North America Ultra Short Acting Anesthetic Revenue Market Share by Type (2017-2028)
Figure 39. North America Ultra Short Acting Anesthetic Sales Market Share by Application (2017-2028)
Figure 40. North America Ultra Short Acting Anesthetic Revenue Market Share by Application (2017-2028)
Figure 41. North America Ultra Short Acting Anesthetic Sales Share by Country (2017-2028)
Figure 42. North America Ultra Short Acting Anesthetic Revenue Share by Country (2017-2028)
Figure 43. United States Ultra Short Acting Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 44. Canada Ultra Short Acting Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 45. Europe Ultra Short Acting Anesthetic Sales Market Share by Type (2017-2028)
Figure 46. Europe Ultra Short Acting Anesthetic Revenue Market Share by Type (2017-2028)
Figure 47. Europe Ultra Short Acting Anesthetic Sales Market Share by Application (2017-2028)
Figure 48. Europe Ultra Short Acting Anesthetic Revenue Market Share by Application (2017-2028)
Figure 49. Europe Ultra Short Acting Anesthetic Sales Share by Country (2017-2028)
Figure 50. Europe Ultra Short Acting Anesthetic Revenue Share by Country (2017-2028)
Figure 51. Germany Ultra Short Acting Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 52. France Ultra Short Acting Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 53. U.K. Ultra Short Acting Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 54. Italy Ultra Short Acting Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 55. Russia Ultra Short Acting Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 56. Asia Pacific Ultra Short Acting Anesthetic Sales Market Share by Type (2017-2028)
Figure 57. Asia Pacific Ultra Short Acting Anesthetic Revenue Market Share by Type (2017-2028)
Figure 58. Asia Pacific Ultra Short Acting Anesthetic Sales Market Share by Application (2017-2028)
Figure 59. Asia Pacific Ultra Short Acting Anesthetic Revenue Market Share by Application (2017-2028)
Figure 60. Asia Pacific Ultra Short Acting Anesthetic Sales Share by Region (2017-2028)
Figure 61. Asia Pacific Ultra Short Acting Anesthetic Revenue Share by Region (2017-2028)
Figure 62. China Ultra Short Acting Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 63. Japan Ultra Short Acting Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 64. South Korea Ultra Short Acting Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 65. India Ultra Short Acting Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 66. Australia Ultra Short Acting Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 67. China Taiwan Ultra Short Acting Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 68. Indonesia Ultra Short Acting Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 69. Thailand Ultra Short Acting Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 70. Malaysia Ultra Short Acting Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 71. Latin America Ultra Short Acting Anesthetic Sales Market Share by Type (2017-2028)
Figure 72. Latin America Ultra Short Acting Anesthetic Revenue Market Share by Type (2017-2028)
Figure 73. Latin America Ultra Short Acting Anesthetic Sales Market Share by Application (2017-2028)
Figure 74. Latin America Ultra Short Acting Anesthetic Revenue Market Share by Application (2017-2028)
Figure 75. Latin America Ultra Short Acting Anesthetic Sales Share by Country (2017-2028)
Figure 76. Latin America Ultra Short Acting Anesthetic Revenue Share by Country (2017-2028)
Figure 77. Mexico Ultra Short Acting Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 78. Brazil Ultra Short Acting Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 79. Argentina Ultra Short Acting Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 80. Middle East and Africa Ultra Short Acting Anesthetic Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Ultra Short Acting Anesthetic Revenue Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Ultra Short Acting Anesthetic Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Ultra Short Acting Anesthetic Revenue Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Ultra Short Acting Anesthetic Sales Share by Country (2017-2028)
Figure 85. Middle East and Africa Ultra Short Acting Anesthetic Revenue Share by Country (2017-2028)
Figure 86. Turkey Ultra Short Acting Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 87. Saudi Arabia Ultra Short Acting Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 88. UAE Ultra Short Acting Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 89. Ultra Short Acting Anesthetic Value Chain
Figure 90. Ultra Short Acting Anesthetic Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed

---